Investment Manager at Navigare Ventures
Check size: Navigare Ventures does not publish one standard current check-size range on its official website.
Salla Franzén invests or supports investment decisions through Navigare Ventures's published strategy: Transform scientific excellence into globally important companies by investing in research-based deep technology and life sciences from early commercialization onward.
Present the scientific breakthrough, validation, intellectual-property position, commercialization route, team and milestones required to cross from research into a scalable company.
Defensible science, world-class research teams, clear commercial applications and technologies with the potential to create large industrial or health outcomes.
No formal pass list is public. Conventional businesses without research depth, scientific differentiation or a credible commercialization path appear less aligned.